Comprehensive Medical Weight Loss Denver
Don’t let your tax-free health dollars expire on December 31st. Here is how to invest them in your metabolic health. As we approach the end of the year in Greenwood Village, the to-do lists are getting longer. Between holiday shopping…
GLP-1 receptor agonists like Ozempic®, Wegovy®, and Zepbound® have become powerful tools in modern weight management. At Clinical Nutrition Center, we see them as a catalyst for profound, sustainable change. However, these medications are not a standalone solution; they are…
As the calendar pages flip closer to the end of the year, a familiar thought often creeps in: “I’ll just enjoy myself through the holidays and get serious about my health in January.” It’s a tempting idea, isn’t it? It…
As the first crisp autumn leaves fall here in Denver, many of us feel a familiar mix of excitement and, if we’re being honest, a little bit of anxiety. The “feast season”—that stretch of holidays from Halloween through New Year’s…
The revolution in medical weight loss, driven by GLP-1 receptor agonists (GLP-1 RAs) such as Zepbound®, Wegovy®, Mounjaro®, and Ozempic®, has been transformative. These medications are powerful tools that correct the underlying biology of obesity, helping patients achieve meaningful results…
We’ve talked a lot about MASH (Metabolic dysfunction-associated steatohepatitis) and the power of weight loss and medication to reverse it. But there’s a simple, free, and incredibly powerful tool you have at your disposal every single day: water. While it…
You may have heard a lot about how weight affects your heart, joints, and even your mood. But what about your liver? Our liver is a powerhouse organ, working tirelessly to filter our blood, store energy, and help with digestion.…
We’re excited to share some important news from the FDA that may impact many of our patients. On August 15, 2025, the FDA approved a new use for Wegovy® (semaglutide 2.4 mg injection)—already well known for weight management and heart…
Today, Eli Lilly announced groundbreaking results from the SURPASS-CVOT trial showing that Mounjaro® (tirzepatide), a once-weekly injectable medication used for type 2 diabetes (and marketed as Zepbound® for obesity), reduced the risk of major adverse cardiovascular events (MACE) by 28%…
From Your CNC Dietitian, Stacy Gill Many people believe that eating fewer calories or smaller portions is the key to lasting weight loss. While this can lead to short-term results, the long-term reality is more complex—and far more important to your overall…
